CompletedNot Applicable

NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

Denmark, Germany, Sweden1,099,551 participantsStarted 2021-07-13

Plain-language summary

A study using medical records to evaluate safety issues for the NOCDURNA drug using national register data from Denmark and Sweden, and a health care register covering parts of Germany.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Usage of NOCDURNA recorded as dispensations in adults or usage of drugs for LUTS. Exclusion Criteria: * Multiple dispensations of NOCDURNA on the same day or treatment with vasopressin 6 months before study start.

What they're measuring

Incidence rate of symptomatic hyponatraemia

Timeframe: Through study completion, typically 2 months

Trial details

NCT IDNCT04740645

SponsorFerring Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-11-01

View on ClinicalTrials.gov More Adverse Drug Event trials